You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 12, 2024

LIDEX-E Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Lidex-e patents expire, and when can generic versions of Lidex-e launch?

Lidex-e is a drug marketed by Alvogen and is included in one NDA.

The generic ingredient in LIDEX-E is fluocinonide. There are nine drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the fluocinonide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Lidex-e

A generic version of LIDEX-E was approved as fluocinonide by TARO on June 10th, 1987.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LIDEX-E?
  • What are the global sales for LIDEX-E?
  • What is Average Wholesale Price for LIDEX-E?
Summary for LIDEX-E
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 72
Patent Applications: 5,214
DailyMed Link:LIDEX-E at DailyMed
Drug patent expirations by year for LIDEX-E

US Patents and Regulatory Information for LIDEX-E

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen LIDEX-E fluocinonide CREAM;TOPICAL 016908-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for LIDEX-E

See the table below for patents covering LIDEX-E around the world.

Country Patent Number Title Estimated Expiration
Netherlands 154665 ⤷  Sign Up
Netherlands 6911091 ⤷  Sign Up
Hong Kong 26976 IMPROVEMENTS IN OR RELATING TO VEHICLES FOR MEDICAMENTS ⤷  Sign Up
United Kingdom 1259858 ⤷  Sign Up
Belgium 737875 ⤷  Sign Up
Sweden 363975 ⤷  Sign Up
Norway 129078 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.